Kenneth Gordon Carson

This inventor holds 38 USPTO granted patents and 14 published patent applications, plus 6 CIPO patents and 15 EPO patents, primarily in Chemokine Receptor Antagonists. Top assignees: Millennium Pharmaceuticals Limited, Lexicon Pharmaceuticals, Inc., Kyowa Hakko Kirin Co., Limited. Active years: 2002-2020.

USPTO Granted Patents = 38 (Patent Applications = 14)

% Patents Active = 57.9

CIPO Patents = 6

EPO Patents = 15 (Patent Applications = 10)

Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 175(Granted Patents)

Location History:

Needham, MA (US) (2002 - 2014)
Princeton, NJ (US) (2009 - 2020)

Company Filing History:

20 out of 854

Millennium Pharmaceuticals Limited

patents

17 out of 89

Lexicon Pharmaceuticals, Inc.

patents

3 out of 272

Kyowa Hakko Kirin Co., Limited

patents

4. 2 out of 3,735

Bristol-Myers Squibb Compnay

patents

5. 2 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

6. 1 out of 1

Carafe Drug Innovation, LLC

patent

where one patent can have more than one assignee

Years Active: 2002-2020

Loading Chart...

Areas of Expertise:

Chemokine Receptor Antagonists

Sodium Glucose Transport Inhibitors

Cancer Treatment Compounds

MST1 Kinase Inhibitors

Rheumatoid Arthritis Treatments

Inflammatory Disease Therapies

Functionalized Heterocycles

Imidazole-based Compounds

4H-thieno[3,2-C]chromene

Pyrazolo[1,5-a]pyrimidine

Substituted Quinoxaline Derivatives

Aryl Alkenamides Derivatives

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10537552 - Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers (2020-01-21),

2. 10106569 - Inhibitors of sodium glucose transporter 1 for constipation (2018-10-23),

3. 9688710 - Inhibitors of sodium glucose cotransporter 1 (2017-06-27),

4. 9663537 - Chemokine receptor antagonists and methods of use (2017-05-30),

5. 9624238 - 4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use (2017-04-18),

6. 9403832 - Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use (2016-08-02),

7. 9334283 - CCR1 antagonists and methods of use thereof (2016-05-10),

8. 9200025 - Inhibitors of sodium glucose cotransporter 1 (2015-12-01),

9. 8969565 - Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use (2015-03-03),

10. 8946415 - Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use (2015-02-03),

11. 8653096 - Chemokine receptor antagonists and methods of use thereof (2014-02-18),

12. 8648197 - Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists (2014-02-11),

13. 8497271 - Modulators of G protein-coupled receptor 88 (2013-07-30),

14. 8440652 - MST1 kinase inhibitors and methods of their use (2013-05-14),

15. 8404732 - Methods of treating ulcerative colitis (2013-03-26),

Title: Kenneth Gordon Carson - The Innovative Mind from Princeton

Introduction: Kenneth Gordon Carson is a renowned inventor hailing from Princeton, NJ, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Kenneth Gordon Carson holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Kenneth Gordon Carson has worked with prestigious research institutions and leading technology companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Kenneth Gordon Carson has collaborated with top universities, cutting-edge startups, and established corporations, fostering a culture of creativity and forward thinking in all his projects.

Conclusion: Kenneth Gordon Carson's passion for innovation and his relentless drive to solve complex problems have solidified his position as a pioneering inventor in the modern technological landscape.